首页 > 最新文献

Journal of Clinical Anesthesia最新文献

英文 中文
PPI and postinduction hypotension: Null association or methodological artifact? PPI和诱导后低血压:无效关联还是方法学伪影?
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-13 DOI: 10.1016/j.jclinane.2025.112108
Yanru Xiang , Mingyue Xia , Xingping Dai
{"title":"PPI and postinduction hypotension: Null association or methodological artifact?","authors":"Yanru Xiang , Mingyue Xia , Xingping Dai","doi":"10.1016/j.jclinane.2025.112108","DOIUrl":"10.1016/j.jclinane.2025.112108","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"110 ","pages":"Article 112108"},"PeriodicalIF":5.1,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145980111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative sleep disturbances: Therapeutic target or epiphenomenon of brain vulnerability? 术前睡眠障碍:治疗目标还是脑易感性的附带现象?
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-09 DOI: 10.1016/j.jclinane.2026.112132
Mattia Madeo , Stefano Fresilli , Andrea Bruni
{"title":"Preoperative sleep disturbances: Therapeutic target or epiphenomenon of brain vulnerability?","authors":"Mattia Madeo , Stefano Fresilli , Andrea Bruni","doi":"10.1016/j.jclinane.2026.112132","DOIUrl":"10.1016/j.jclinane.2026.112132","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"110 ","pages":"Article 112132"},"PeriodicalIF":5.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145923705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the Cover - King et al 封面上——国王等人
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-09 DOI: 10.1016/S0952-8180(26)00002-4
{"title":"On the Cover - King et al","authors":"","doi":"10.1016/S0952-8180(26)00002-4","DOIUrl":"10.1016/S0952-8180(26)00002-4","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112124"},"PeriodicalIF":5.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145938767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Board w/barcode 编辑委员会/条形码
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-09 DOI: 10.1016/S0952-8180(26)00004-8
{"title":"Editorial Board w/barcode","authors":"","doi":"10.1016/S0952-8180(26)00004-8","DOIUrl":"10.1016/S0952-8180(26)00004-8","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112126"},"PeriodicalIF":5.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145938763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of preoperative sleep disturbance on perioperative neurocognitive disorders in older adults undergoing major non-cardiac surgery: A multicenter prospective cohort study 术前睡眠障碍对接受重大非心脏手术的老年人围手术期神经认知障碍的影响:一项多中心前瞻性队列研究
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-07 DOI: 10.1016/j.jclinane.2026.112123
Chao Chen , Shengfeng Yang , Yewei Shi , Zhenyan Zhu , Xinglong Xiong , Ling Huang , Jun Lu , Guangling Tang , Xianzhou Gu , Guangdi Zhang , Yu Wan , Ruixue Zhai , Sijie Tang , Yuanyu Feng , Yusu Wang , Jielei Pan , Jing Shi

Background

Perioperative neurocognitive disorders (PND) significantly affect recovery in older adult surgical patients. However, whether untreated preoperative sleep disturbance (SD) independently contributes to postoperative cognitive dysfunction (POCD) remains unclear.

Methods

This multicenter prospective cohort study involving 535 patients aged ≥60 years undergoing major non-cardiac surgery (≥2 h) was conducted between June 30, 2024 and May 31, 2025. Patients were stratified by Pittsburgh Sleep Quality Index (PSQI): SD (PSQI>7, n = 288) or non-SD (PSQI≤7, n = 247). The primary outcome was POCD assessed on postoperative days 7, 30, 90, and 180. Secondary outcomes included postoperative delirium (days 1–3), 15-item quality of recovery (QoR-15) scores, and insomnia severity (days 30, 90, and 180). Generalized estimating equations identified independent predictors of POCD.

Results

Compared with non-SD patients, SD patients showed significantly increased POCD risk on postoperative day 7 (41.7 % vs. 27.1 %; RR = 1.44, 95 %CI 1.16–1.79; P < 0.001), day 30 (36.1 % vs. 18.2 %; RR = 1.73, 95 %CI 1.33–2.25; P < 0.001), day 90 (25.7 % vs. 13.0 %; RR = 1.66, 95 %CI 1.22–2.25; P < 0.001), and day 180 (19.4 % vs. 8.9 %; RR = 1.75, 95 %CI 1.21–2.52; P < 0.001). Preoperative SD was associated with increased delirium risk (29.9 % vs. 18.6 %; RR = 1.43, P = 0.006), poorer QoR-15 scores (difference = 8, P < 0.001), and persistent insomnia (34.7 % vs. 13.8 % at day 180, P < 0.001). PSQI≥10 optimally predicted POCD risk (sensitivity 71.8 %, specificity 69.4 %).

Conclusions

Untreated preoperative SD independently predicts both early delirium and POCD after major non-cardiac surgery. A PSQI≥10 effectively identifies high-risk older adult patients, emphasizing preoperative sleep optimization as a potential strategy to mitigate postoperative cognitive impairment.
背景围手术期神经认知障碍(PND)显著影响老年外科患者的康复。然而,术前未治疗的睡眠障碍(SD)是否会独立导致术后认知功能障碍(POCD)仍不清楚。方法本多中心前瞻性队列研究于2024年6月30日至2025年5月31日进行,纳入535例年龄≥60岁、接受重大非心脏手术(≥2小时)的患者。采用匹兹堡睡眠质量指数(PSQI)对患者进行分层:SD (PSQI>7, n = 288)和非SD (PSQI≤7,n = 247)。术后7天、30天、90天和180天评估POCD。次要结局包括术后谵妄(1-3天)、15项恢复质量(QoR-15)评分和失眠严重程度(30、90和180天)。广义估计方程确定了POCD的独立预测因子。结果与非SD患者相比,SD患者术后第7天(41.7% vs. 27.1%; RR = 1.44, 95% CI 1.16-1.79; P < 0.001)、第30天(36.1% vs. 18.2%; RR = 1.73, 95% CI 1.33-2.25; P < 0.001)、第90天(25.7% vs. 13.0%; RR = 1.66, 95% CI 1.22-2.25; P < 0.001)、第180天(19.4% vs. 8.9%; RR = 1.75, 95% CI 1.21-2.52; P < 0.001)的POCD风险显著增加。术前SD与谵妄风险增加(29.9% vs. 18.6%; RR = 1.43, P = 0.006)、较差的QoR-15评分(差异= 8,P < 0.001)和持续失眠(第180天34.7% vs. 13.8%, P < 0.001)相关。PSQI≥10最能预测POCD风险(敏感性71.8%,特异性69.4%)。结论术前经治疗的SD可独立预测重大非心脏手术后早期谵妄和POCD。PSQI≥10有效识别高危老年患者,强调术前睡眠优化是减轻术后认知障碍的潜在策略。
{"title":"Impact of preoperative sleep disturbance on perioperative neurocognitive disorders in older adults undergoing major non-cardiac surgery: A multicenter prospective cohort study","authors":"Chao Chen ,&nbsp;Shengfeng Yang ,&nbsp;Yewei Shi ,&nbsp;Zhenyan Zhu ,&nbsp;Xinglong Xiong ,&nbsp;Ling Huang ,&nbsp;Jun Lu ,&nbsp;Guangling Tang ,&nbsp;Xianzhou Gu ,&nbsp;Guangdi Zhang ,&nbsp;Yu Wan ,&nbsp;Ruixue Zhai ,&nbsp;Sijie Tang ,&nbsp;Yuanyu Feng ,&nbsp;Yusu Wang ,&nbsp;Jielei Pan ,&nbsp;Jing Shi","doi":"10.1016/j.jclinane.2026.112123","DOIUrl":"10.1016/j.jclinane.2026.112123","url":null,"abstract":"<div><h3>Background</h3><div>Perioperative neurocognitive disorders (PND) significantly affect recovery in older adult surgical patients. However, whether untreated preoperative sleep disturbance (SD) independently contributes to postoperative cognitive dysfunction (POCD) remains unclear.</div></div><div><h3>Methods</h3><div>This multicenter prospective cohort study involving 535 patients aged ≥60 years undergoing major non-cardiac surgery (≥2 h) was conducted between June 30, 2024 and May 31, 2025. Patients were stratified by Pittsburgh Sleep Quality Index (PSQI): SD (PSQI&gt;7, <em>n</em> = 288) or non-SD (PSQI≤7, <em>n</em> = 247). The primary outcome was POCD assessed on postoperative days 7, 30, 90, and 180. Secondary outcomes included postoperative delirium (days 1–3), 15-item quality of recovery (QoR-15) scores, and insomnia severity (days 30, 90, and 180). Generalized estimating equations identified independent predictors of POCD.</div></div><div><h3>Results</h3><div>Compared with non-SD patients, SD patients showed significantly increased POCD risk on postoperative day 7 (41.7 % vs. 27.1 %; RR = 1.44, 95 %CI 1.16–1.79; <em>P</em> &lt; 0.001), day 30 (36.1 % vs. 18.2 %; RR = 1.73, 95 %CI 1.33–2.25; <em>P</em> &lt; 0.001), day 90 (25.7 % vs. 13.0 %; RR = 1.66, 95 %CI 1.22–2.25; <em>P</em> &lt; 0.001), and day 180 (19.4 % vs. 8.9 %; RR = 1.75, 95 %CI 1.21–2.52; <em>P</em> &lt; 0.001). Preoperative SD was associated with increased delirium risk (29.9 % vs. 18.6 %; RR = 1.43, <em>P</em> = 0.006), poorer QoR-15 scores (difference = 8, <em>P</em> &lt; 0.001), and persistent insomnia (34.7 % vs. 13.8 % at day 180, <em>P</em> &lt; 0.001). PSQI≥10 optimally predicted POCD risk (sensitivity 71.8 %, specificity 69.4 %).</div></div><div><h3>Conclusions</h3><div>Untreated preoperative SD independently predicts both early delirium and POCD after major non-cardiac surgery. A PSQI≥10 effectively identifies high-risk older adult patients, emphasizing preoperative sleep optimization as a potential strategy to mitigate postoperative cognitive impairment.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"110 ","pages":"Article 112123"},"PeriodicalIF":5.1,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145903816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intravenous ferric derisomaltose for preoperative anemia in abdominal surgery 静脉注射脱异麦芽糖铁治疗腹部手术术前贫血
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jclinane.2025.112107
Eduardo Mendez-Pino , Laura Ibanez-Pintor , Laura Mendez-Pino , Andres Zorrilla-Vaca , David L. Hepner

Background

There is increasing evidence supporting the use of intravenous (IV) iron in the perioperative setting, which has been shown to improve hemoglobin levels and reduce the need for transfusion. This study aimed to evaluate the efficacy of a single preoperative IV infusion of ferric derisomaltose administered 3 to 4 weeks prior to abdominal surgery in increasing hemoglobin (Hb) levels.

Methods

This single arm prospective trial with pos-hoc matched controls included adult patients with preoperative iron deficiency anemia (Hb ≤ 12 g/dL, and ferritin<30 ng/mL or transferrin saturation < 20 %) scheduled for abdominal surgery and treated with 1000 mg of IV ferric derisomaltose 3–4 weeks prior to surgery. The primary outcome was the change in Hb from baseline to the day of surgery. Between-group comparisons were performed using the paired t-test. A random control cohort who met our inclusion criteria but did not receive the treatment was included in a post-hoc analysis to evaluate associations with in-hospital blood transfusion.

Results

Among 36 patients treated with IV ferric derisomaltose, there was a significant improvement in hemoglobin levels after 3–4 weeks of drug administration (mean difference [MD] 1.88 g/dL, 95 % confidence interval [CI] 1.40 to 2.36) and after surgery (MD 0.67 g/dL, 95 %CI 0.16 to 1.17). Patients with moderate-to-severe pre-infusion anemia (Hb ≤ 10 g/dL) had a significantly superior improvement in Hb levels compared to patients with mild anemia (P = 0.03). In post-hoc analysis including a control group, transfusion rate was similar between the treated and control group (odds ratio 1.00, 95 %CI 0.29–3.48).

Conclusion

In this preliminary report with limited sample size, our findings suggest that a single preoperative dose of 1000 mg of IV ferric derisomaltose improves hemoglobin levels. Its ability to provide timely optimization before surgery warrants further investigation in large-scale trials to better define its role in perioperative care.
背景:越来越多的证据支持围手术期静脉注射(IV)铁,这已被证明可以提高血红蛋白水平并减少输血需求。本研究旨在评估腹部手术前3至4周单次静脉输注三异麦牙糖铁对提高血红蛋白(Hb)水平的疗效。方法:该单臂前瞻性试验纳入了术前缺铁性贫血(Hb≤12 g/dL,铁蛋白≤30 ng/mL或转铁蛋白饱和度≤20%)的成年患者,这些患者计划进行腹部手术,并在手术前3-4周静脉注射1000mg脱异麦糖铁。主要结局是Hb从基线到手术当天的变化。组间比较采用配对t检验。符合纳入标准但未接受治疗的随机对照队列纳入事后分析,以评估与院内输血的关系。结果36例静脉注射脱异麦糖铁治疗的患者,在给药3-4周后(平均差值[MD] 1.88 g/dL, 95%可信区间[CI] 1.40 ~ 2.36)和手术后(MD = 0.67 g/dL, 95%可信区间[CI] 0.16 ~ 1.17)血红蛋白水平均有显著改善。与轻度贫血患者相比,中重度输注前贫血(Hb≤10 g/dL)患者的Hb水平改善明显优于轻度贫血患者(P = 0.03)。在包括对照组的事后分析中,治疗组和对照组的输血率相似(优势比1.00,95% CI 0.29-3.48)。在这份样本量有限的初步报告中,我们的研究结果表明,术前单次静脉注射1000mg二异麦芽糖铁可改善血红蛋白水平。它在手术前提供及时优化的能力值得在大规模试验中进一步研究,以更好地确定其在围手术期护理中的作用。
{"title":"Intravenous ferric derisomaltose for preoperative anemia in abdominal surgery","authors":"Eduardo Mendez-Pino ,&nbsp;Laura Ibanez-Pintor ,&nbsp;Laura Mendez-Pino ,&nbsp;Andres Zorrilla-Vaca ,&nbsp;David L. Hepner","doi":"10.1016/j.jclinane.2025.112107","DOIUrl":"10.1016/j.jclinane.2025.112107","url":null,"abstract":"<div><h3>Background</h3><div>There is increasing evidence supporting the use of intravenous (IV) iron in the perioperative setting, which has been shown to improve hemoglobin levels and reduce the need for transfusion. This study aimed to evaluate the efficacy of a single preoperative IV infusion of ferric derisomaltose administered 3 to 4 weeks prior to abdominal surgery in increasing hemoglobin (Hb) levels.</div></div><div><h3>Methods</h3><div>This single arm prospective trial with pos-hoc matched controls included adult patients with preoperative iron deficiency anemia (Hb ≤ 12 g/dL, and ferritin&lt;30 ng/mL or transferrin saturation &lt; 20 %) scheduled for abdominal surgery and treated with 1000 mg of IV ferric derisomaltose 3–4 weeks prior to surgery. The primary outcome was the change in Hb from baseline to the day of surgery. Between-group comparisons were performed using the paired <em>t-</em>test. A random control cohort who met our inclusion criteria but did not receive the treatment was included in a <em>post-hoc</em> analysis to evaluate associations with in-hospital blood transfusion.</div></div><div><h3>Results</h3><div>Among 36 patients treated with IV ferric derisomaltose, there was a significant improvement in hemoglobin levels after 3–4 weeks of drug administration (mean difference [MD] 1.88 g/dL, 95 % confidence interval [CI] 1.40 to 2.36) and after surgery (MD 0.67 g/dL, 95 %CI 0.16 to 1.17). Patients with moderate-to-severe pre-infusion anemia (Hb ≤ 10 g/dL) had a significantly superior improvement in Hb levels compared to patients with mild anemia (<em>P</em> = 0.03). In <em>post-hoc</em> analysis including a control group, transfusion rate was similar between the treated and control group (odds ratio 1.00, 95 %CI 0.29–3.48).</div></div><div><h3>Conclusion</h3><div>In this preliminary report with limited sample size, our findings suggest that a single preoperative dose of 1000 mg of IV ferric derisomaltose improves hemoglobin levels. Its ability to provide timely optimization before surgery warrants further investigation in large-scale trials to better define its role in perioperative care.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112107"},"PeriodicalIF":5.1,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145880369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of prehabilitation interventions on exercise capacity of patients undergoing major abdominal and cardiothoracic surgery: A systematic review and network meta-analysis of randomized controlled trials 康复干预对腹、心胸外科大手术患者运动能力的影响:随机对照试验的系统回顾和网络荟萃分析
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jclinane.2025.112112
Susana Priego-Jiménez PhD , Pablo Priego Jiménez PhD , María López-González MsC , Patricia Lorenzo-García PhD , Miguel Contreras-Molina MsC , Celia Álvarez-Bueno PhD

Background

Prehabilitation has reported improvements in exercise capacity, as measured by the six-minute walking test (6MWT), in people undergoing major abdominal and cardiothoracic surgery, although there is no evidence about which component of prehabilitation is most effective for improving exercise capacity.

Methods

A network meta-analysis (NMA) was performed to determine the effects of different components of prehabilitation on exercise capacity in people undergoing major abdominal or cardiothoracic surgery. A literature search was performed from baseline to September 2025. Randomized controlled trials on the effectiveness of prehabilitation programs on exercise capacity presurgery and recovery postsurgery were included. We assessed the risk of bias via the Cochrane risk of bias (RoB 2.0) tool and the quality of the evidence via the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool. Pairwise meta-analyses and NMAs were performed for direct and indirect evidence.

Results

Thirty-eight studies were included in this NMA. The effects associated with improvements in exercise capacity presurgery scores were greatest for the moderate-intensity exercise group versus control group (Effect size [ES]: 0.93 95 % CI: 0.46, 1.40), followed by the multimodal group (exercise+ nutrition + psychological intervention) versus the control group (ES: 0.50, 95 % CI: 0.15, 0.86). The effects associated with 6MWT recovery postsurgery score were greatest for the exercise+ nutrition group versus the control group (ES: 1.08, 95 % CI: 0.00, 2.16), followed by the moderate-intensity exercise group versus the control group (ES: 0.55, 95 % CI: 0.08, 1.01), and the multimodal group versus the control group (ES: 0.35, 95 % CI: 0.03, 0.68).

Conclusions

Moderate-intensity exercise, followed by multimodal exercise, should be considered the most effective strategy for improving exercise capacity in people undergoing major abdominal and cardiothoracic surgery. Exercise plus nutrition is the most effective intervention to improve 6MWT recovery postsurgery, followed by moderate-intensity exercise and multimodal interventions. Owing to the importance of this outcome, as a predictor of both postsurgical complications and recovery capacity after surgery, it is essential to know the most effective intervention to improve it.
背景:据报道,通过6分钟步行测试(6MWT),在接受重大腹部和心胸外科手术的患者中,预康复可以改善运动能力,尽管没有证据表明哪种预康复对提高运动能力最有效。方法采用网络meta分析(network meta-analysis, NMA)确定不同康复成分对大腹或心胸手术患者运动能力的影响。从基线至2025年9月进行文献检索。纳入了康复计划对术前运动能力和术后恢复的有效性的随机对照试验。我们通过Cochrane偏倚风险(RoB 2.0)工具评估偏倚风险,通过推荐、评估、发展和评价分级(GRADE)工具评估证据质量。对直接和间接证据进行两两荟萃分析和nma。结果共纳入38项研究。中等强度运动组与对照组相比,手术前运动能力改善的效果最大(效应量[ES]: 0.93 95% CI: 0.46, 1.40),其次是多模式组(运动+营养+心理干预)与对照组相比(ES: 0.50, 95% CI: 0.15, 0.86)。与对照组相比,运动+营养组对术后6MWT恢复评分的影响最大(ES: 1.08, 95% CI: 0.00, 2.16),其次是中等强度运动组与对照组相比(ES: 0.55, 95% CI: 0.08, 1.01),多模式组与对照组相比(ES: 0.35, 95% CI: 0.03, 0.68)。结论中等强度运动加多模式运动是提高大胸腹外科手术患者运动能力的最有效方法。运动加营养是改善术后6MWT恢复最有效的干预措施,其次是中等强度运动和多模式干预。由于这一结果的重要性,作为术后并发症和术后恢复能力的预测指标,了解最有效的干预措施来改善它是至关重要的。
{"title":"Efficacy of prehabilitation interventions on exercise capacity of patients undergoing major abdominal and cardiothoracic surgery: A systematic review and network meta-analysis of randomized controlled trials","authors":"Susana Priego-Jiménez PhD ,&nbsp;Pablo Priego Jiménez PhD ,&nbsp;María López-González MsC ,&nbsp;Patricia Lorenzo-García PhD ,&nbsp;Miguel Contreras-Molina MsC ,&nbsp;Celia Álvarez-Bueno PhD","doi":"10.1016/j.jclinane.2025.112112","DOIUrl":"10.1016/j.jclinane.2025.112112","url":null,"abstract":"<div><h3>Background</h3><div>Prehabilitation has reported improvements in exercise capacity, as measured by the six-minute walking test (6MWT), in people undergoing major abdominal and cardiothoracic surgery, although there is no evidence about which component of prehabilitation is most effective for improving exercise capacity.</div></div><div><h3>Methods</h3><div>A network meta-analysis (NMA) was performed to determine the effects of different components of prehabilitation on exercise capacity in people undergoing major abdominal or cardiothoracic surgery. A literature search was performed from baseline to September 2025. Randomized controlled trials on the effectiveness of prehabilitation programs on exercise capacity presurgery and recovery postsurgery were included. We assessed the risk of bias via the Cochrane risk of bias (RoB 2.0) tool and the quality of the evidence via the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool. Pairwise meta-analyses and NMAs were performed for direct and indirect evidence.</div></div><div><h3>Results</h3><div>Thirty-eight studies were included in this NMA. The effects associated with improvements in exercise capacity presurgery scores were greatest for the moderate-intensity exercise group versus control group (Effect size [ES]: 0.93 95 % CI: 0.46, 1.40), followed by the multimodal group (exercise+ nutrition + psychological intervention) versus the control group (ES: 0.50, 95 % CI: 0.15, 0.86). The effects associated with 6MWT recovery postsurgery score were greatest for the exercise+ nutrition group versus the control group (ES: 1.08, 95 % CI: 0.00, 2.16), followed by the moderate-intensity exercise group versus the control group (ES: 0.55, 95 % CI: 0.08, 1.01), and the multimodal group versus the control group (ES: 0.35, 95 % CI: 0.03, 0.68).</div></div><div><h3>Conclusions</h3><div>Moderate-intensity exercise, followed by multimodal exercise, should be considered the most effective strategy for improving exercise capacity in people undergoing major abdominal and cardiothoracic surgery. Exercise plus nutrition is the most effective intervention to improve 6MWT recovery postsurgery, followed by moderate-intensity exercise and multimodal interventions. Owing to the importance of this outcome, as a predictor of both postsurgical complications and recovery capacity after surgery, it is essential to know the most effective intervention to improve it.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112112"},"PeriodicalIF":5.1,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145880472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) use in a pediatric population: A prospective, randomized controlled trial 经鼻加湿快速充气通气交换(THRIVE)在儿科人群中的应用:一项前瞻性、随机对照试验
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jclinane.2025.112117
Ellen Y. Wang MD , Andrew J. Renuart MD , Stephen G. Flynn MD , Hanna Van Pelt BS , Prabhakar Devavaram MBBS , Linda A. Bulich MD , Mary Lyn Stein MD , Niroop R. Ravula MD, FRCA , Rajvinder S. Dhamrait MD, MBA, FCARCSI, FRCA , Kristin M. Kennedy MD , Man Yee Suen MMedSc , Christian Jackson MS , Kush Gupta MD , Alex Swanger MD , Romy Yun MD , Michael A. Evans MD, FAAP, FASA , Vanessa A. Olbrecht MD , Thomas J. Caruso MD, PhD

Background

Maintenance of oxygenation during microdirect laryngoscopy and bronchoscopy (MDLB) is an anesthetic challenge for pediatric anesthesia providers. High flow nasal cannula (HFNC) as transnasal humidified rapid insufflation ventilatory exchange (THRIVE) is a safe method to deliver humidified oxygen to pediatric patients; however, its role in pediatrics for preventing apneic desaturation while under anesthesia is unclear. This study evaluated THRIVE for pediatric patients undergoing airway procedures. The primary aim was to assess the frequency of patients who had at least one “relative desaturation” event, assessed as a 4 % drop from a patient's average baseline saturation using the measure of oxygen desaturation index (ODI). The secondary aims assessed frequencies of total relative desaturation events, absolute desaturations below 90 % and surgical interruptions due to airway conditions.

Methods

This was a prospective, randomized controlled trial conducted across three pediatric sites (Lucile Packard Children's Hospital [Stanford University, Palo Alto, CA], UC Davis Children's Hospital [University of California, Davis, CA], and Boston Children's Hospital [Harvard University, Boston, MA]). Participants between the ages of 2 months to 18 years underwent airway examinations or airway procedures under general anesthesia. Participants were randomized in a 1:1 ratio to THRIVE or standard of care (SOC).

Results

A total of 144 participants were included. ODI measurements of relative desaturation in the THRIVE group and SOC group showed no differences in number of the participants who ever desaturated (p = 0.18). There was a difference in total number of relative desaturation events, accounting for multiple events per participant (p = 0.04). There were no differences in surgical interruptions due to airway conditions.

Conclusion

THRIVE was not superior to SOC for reducing the number of patients who experienced desaturations or surgical interruptions, though it may have some benefit for reducing the total number of desaturation events in those who desaturate.
背景:在微直接喉镜和支气管镜检查(MDLB)期间维持氧合是儿科麻醉提供者面临的一个麻醉挑战。高流量鼻插管(HFNC)作为经鼻湿化快速充气通气交换器(THRIVE)是一种安全的儿科湿化氧气输送方法;然而,它在儿科预防麻醉下呼吸暂停去饱和的作用尚不清楚。本研究评估了THRIVE在接受气道手术的儿科患者中的应用。主要目的是评估至少发生一次“相对去饱和”事件的患者频率,使用氧去饱和指数(ODI)测量,以患者平均基线饱和度下降4%进行评估。次要目的评估总相对去饱和事件的频率,绝对去饱和低于90%和由于气道状况导致的手术中断。方法:这是一项前瞻性、随机对照试验,在三个儿科机构进行(Lucile Packard儿童医院[斯坦福大学,帕洛阿尔托,加利福尼亚州]、UC Davis儿童医院[加州大学戴维斯分校]和波士顿儿童医院[哈佛大学,波士顿,马萨诸塞州])。年龄在2个月至18岁之间的参与者在全身麻醉下接受气道检查或气道手术。参与者按1:1的比例随机分配到THRIVE或标准护理(SOC)。结果共纳入144名受试者。在THRIVE组和SOC组的相对去饱和ODI测量中,曾经去饱和的参与者数量没有差异(p = 0.18)。相对去饱和事件的总数存在差异,考虑到每个参与者的多个事件(p = 0.04)。由于气道状况导致的手术中断没有差异。结论thrive在减少失饱和或手术中断的患者数量方面并不优于SOC,尽管它可能在减少失饱和患者的失饱和事件总数方面具有一定的优势。
{"title":"Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) use in a pediatric population: A prospective, randomized controlled trial","authors":"Ellen Y. Wang MD ,&nbsp;Andrew J. Renuart MD ,&nbsp;Stephen G. Flynn MD ,&nbsp;Hanna Van Pelt BS ,&nbsp;Prabhakar Devavaram MBBS ,&nbsp;Linda A. Bulich MD ,&nbsp;Mary Lyn Stein MD ,&nbsp;Niroop R. Ravula MD, FRCA ,&nbsp;Rajvinder S. Dhamrait MD, MBA, FCARCSI, FRCA ,&nbsp;Kristin M. Kennedy MD ,&nbsp;Man Yee Suen MMedSc ,&nbsp;Christian Jackson MS ,&nbsp;Kush Gupta MD ,&nbsp;Alex Swanger MD ,&nbsp;Romy Yun MD ,&nbsp;Michael A. Evans MD, FAAP, FASA ,&nbsp;Vanessa A. Olbrecht MD ,&nbsp;Thomas J. Caruso MD, PhD","doi":"10.1016/j.jclinane.2025.112117","DOIUrl":"10.1016/j.jclinane.2025.112117","url":null,"abstract":"<div><h3>Background</h3><div>Maintenance of oxygenation during microdirect laryngoscopy and bronchoscopy (MDLB) is an anesthetic challenge for pediatric anesthesia providers. High flow nasal cannula (HFNC) as transnasal humidified rapid insufflation ventilatory exchange (THRIVE) is a safe method to deliver humidified oxygen to pediatric patients; however, its role in pediatrics for preventing apneic desaturation while under anesthesia is unclear. This study evaluated THRIVE for pediatric patients undergoing airway procedures. The primary aim was to assess the frequency of patients who had at least one “relative desaturation” event, assessed as a 4 % drop from a patient's average baseline saturation using the measure of oxygen desaturation index (ODI). The secondary aims assessed frequencies of total relative desaturation events, absolute desaturations below 90 % and surgical interruptions due to airway conditions.</div></div><div><h3>Methods</h3><div>This was a prospective, randomized controlled trial conducted across three pediatric sites (Lucile Packard Children's Hospital [Stanford University, Palo Alto, CA], UC Davis Children's Hospital [University of California, Davis, CA], and Boston Children's Hospital [Harvard University, Boston, MA]). Participants between the ages of 2 months to 18 years underwent airway examinations or airway procedures under general anesthesia. Participants were randomized in a 1:1 ratio to THRIVE or standard of care (SOC).</div></div><div><h3>Results</h3><div>A total of 144 participants were included. ODI measurements of relative desaturation in the THRIVE group and SOC group showed no differences in number of the participants who ever desaturated (<em>p</em> = 0.18). There was a difference in total number of relative desaturation events, accounting for multiple events per participant (<em>p</em> = 0.04). There were no differences in surgical interruptions due to airway conditions.</div></div><div><h3>Conclusion</h3><div>THRIVE was not superior to SOC for reducing the number of patients who experienced desaturations or surgical interruptions, though it may have some benefit for reducing the total number of desaturation events in those who desaturate.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112117"},"PeriodicalIF":5.1,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145880475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The PAPE block: Ultrasound-guided pericapsular anterior and posterior elbow nerve group block for motor-sparing analgesia PAPE阻滞:超声引导下肘关节囊前后神经组阻滞用于保运动镇痛
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.jclinane.2025.112121
Qingyu Teng MM, Zhiqiang Qian MM, Sijia Yao MM, Qi Li MM, Tao Xu Ph.D, M.D
{"title":"The PAPE block: Ultrasound-guided pericapsular anterior and posterior elbow nerve group block for motor-sparing analgesia","authors":"Qingyu Teng MM,&nbsp;Zhiqiang Qian MM,&nbsp;Sijia Yao MM,&nbsp;Qi Li MM,&nbsp;Tao Xu Ph.D, M.D","doi":"10.1016/j.jclinane.2025.112121","DOIUrl":"10.1016/j.jclinane.2025.112121","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112121"},"PeriodicalIF":5.1,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145880473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-time visualization for post-pyloric feeding tube placement using a biologically transparent illumination device 使用生物透明照明装置进行幽门后饲管放置的实时可视化
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-02 DOI: 10.1016/j.jclinane.2025.112122
Kazufumi Yaginuma M.D. , Tatsuya Nagano M.D., Ph.D , Akihiro Suzuki M.D., Ph.D , Mamoru Takeuchi M.D., Ph.D
{"title":"Real-time visualization for post-pyloric feeding tube placement using a biologically transparent illumination device","authors":"Kazufumi Yaginuma M.D. ,&nbsp;Tatsuya Nagano M.D., Ph.D ,&nbsp;Akihiro Suzuki M.D., Ph.D ,&nbsp;Mamoru Takeuchi M.D., Ph.D","doi":"10.1016/j.jclinane.2025.112122","DOIUrl":"10.1016/j.jclinane.2025.112122","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112122"},"PeriodicalIF":5.1,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145880474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Anesthesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1